Placental function is critically dependent on adequate oxygen supply, and disruptions in oxygenation are closely linked to adverse pregnancy outcomes such as preeclampsia, intrauterine growth restriction (IUGR), and placental insufficiency. Hypoxia, particularly during early placental development, impairs trophoblast invasion and spiral artery remodeling, leading to reduced uteroplacental perfusion and intermittent hypoxia. These conditions compromise nutrient transport across the placenta, especially the transfer of essential amino acids vital for fetal growth. Two major amino acid transport systems—System A and System L—are central to this process. System A mediates sodium-dependent uptake of small neutral amino acids like alanine, serine, and glutamine, while System L facilitates the transport of branched-chain essential amino acids such as leucine and phenylalanine through a sodium-independent mechanism. Both systems are regulated by key intracellular signaling pathways including mTOR and JAK/STAT, which respond dynamically to changes in oxygen tension and metabolic demand.
This study investigated how hypoxia and two commonly used anticoagulants—dalteparin (a low-molecular-weight heparin) and acetylsalicylic acid (ASA)—affect the activity of placental System A and System L transporters. Using primary villous fragments isolated from term placentas, we exposed tissues to varying oxygen levels (2%, 8%, and 21% O₂) and tested the impact of dalteparin and ASA under normoxic and hypoxic conditions. Radiolabeled substrates ([¹⁴C]-MeAIB for System A and [³H]-leucine for System L) were used to measure transporter activity, with non-mediated uptake subtracted to determine specific transport. Our results revealed that hypoxia significantly decreased System A activity by 27% compared to standard culture conditions (21% O₂), while System L activity increased by 42%. At an intermediate oxygen level of 8% O₂, System A remained unchanged, but System L activity rose by 76%, suggesting a differential response based on oxygen concentration.
These functional changes were accompanied by alterations in intracellular signaling. Hypoxia reduced phosphorylation of STAT3—a key component of the JAK/STAT pathway—while enhancing phosphorylation of Raptor, a critical subunit of mTORC1. This shift indicates suppression of STAT3-mediated transcriptional regulation and activation of mTOR-driven anabolic processes. Notably, neither dalteparin nor ASA reversed these hypoxia-induced effects. Under normoxic conditions, dalteparin reduced both System A and System L activities in a dose-dependent manner, with up to 22% and 31% inhibition at higher concentrations. Similarly, ASA at 1 mM significantly impaired both transport systems under both normoxic and hypoxic conditions, with no protective effect observed.Zinc Pyrithione In Vitro Western blot analysis confirmed that dalteparin suppressed STAT3 phosphorylation under hypoxia, while ASA had minimal impact on either pathway.Canagliflozin impurity 79 Epigenetics
Importantly, tissue viability was preserved across all experimental conditions, as evidenced by stable LDH release and consistent hCG secretion, ruling out cell death or loss of function as confounding factors.PMID:35074681 These findings underscore the profound influence of oxygen availability on placental nutrient transport and highlight that therapeutic anticoagulants do not mitigate hypoxic damage. Instead, they may independently impair amino acid transport, potentially compromising fetal growth even in the absence of placental pathology. The data suggest that the mTOR and JAK/STAT pathways serve as key regulators linking oxygen status to placental function. Understanding these mechanisms is crucial for refining clinical use of anticoagulants in high-risk pregnancies, particularly avoiding their administration in late gestation where fetal nutrient demands are maximal. Future research should explore whether targeting these signaling pathways could offer novel strategies to improve placental efficiency without interfering with established therapies.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com